Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

Post by Looneytuneson Dec 02, 2020 5:53pm
314 Views
Post# 32022959

wtf

wtfThis is starting to be really tedious; its clear that the bod have absolutely no clue as to how to move this forwards, they've failed to get agreement from the TSX, have produced no proposals as to how they are going to fund progression and now we're looking at the end of Q1 2021 at the very earliest before any realistic progress will be made. How on earth they expect to ahve this passed by the FDA in 12 months is beyond me; its a completey unrealistic expectation. Their lack of experience is clear but more worrying is their inability to ask for help. the one positive I take from this is that Bakema will come out of this with the same as us shareholders - nothing . . .c'mon bod WAKE UP and stat engaging with the resturucturing group . . .you KNOW it makes sense.
<< Previous
Bullboard Posts
Next >>